Skip to main content
Open Access Publications from the University of California


UC San Francisco Previously Published Works bannerUCSF

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: A randomized controlled trial

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View